Evidence map›Paper›PMID 19008532›Full record

ReviewArteriosclerosis, thrombosis, and vascular biology2009

The opening act: vasculogenesis and the origins of circulation.

Suk-Won Jin, Cam Patterson

Abstract readReview
In one paragraph

Review in Arteriosclerosis, thrombosis, and vascular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. The effect of palm oil-derived tocotrienol-rich fraction in preserving normal retinal vascular diameter in streptozotocin-induced diabetic rats.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Angiogenesis, Cancer, and Vascular Aging.Frontiers in cardiovascular medicine · 2017
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Fox(y) regulators of VEGF receptors.Circulation research · 2014
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Suk-Won JinCarolina Cardiovascular Biology Center, University of North Carolina, Chapel Hill, NC 27599-7126, USA.
Cam Patterson

Funding

Signaling in endothelial growth & angiogenesisR01HL061656 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PI, XINCHUN · 1999 to 2017
$5.8M
NHLBI NIH HHS R01 HL061656
6 · The paper itself

Abstract

Previous studies on cellular and molecular mechanisms that regulate vascular development identified key signaling pathways and transcription factors. These findings supported the notion that the formation of vasculature is predominantly regulated by genetic programs, which is generally accepted. However, recent progress in understanding nongenetic factors that can modify the preprogrammed genetic mechanisms added another layer of complexity to our current understanding of vascular development. Here, we briefly summarize historic viewpoints and evolutionary perspectives on vascular development. We also review the cellular and molecular mechanisms that govern the emergence of the endothelial lineage and the subsequent process of vasculogenesis during development, with an emphasis on vascular endothelial growth factor and angiopoietin signaling cascades. Finally, we discuss epigenetic factors such as hemodynamic forces and hypoxic responses that can modulate and override the predetermined genetic mechanisms of vascular development.

Indexed as

AngiopoietinsBlood VesselsEndothelial CellsEpigenesis, GeneticHumansNeovascularization, PhysiologicSignal TransductionVascular Endothelial Growth Factor AAngiopoietinsVascular Endothelial Growth Factor A

Identifiers

PMID19008532
PMCPMC3432309

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.